|
TDRD7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.71390000003324E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.16209999999562E-05 |
| Normal-vs-Stage2 |
1.752430E-02 |
| Normal-vs-Stage3 |
9.143000E-03 |
| Normal-vs-Stage4 |
4.271900E-02 |
| Stage1-vs-Stage2 |
4.570200E-01 |
| Stage1-vs-Stage3 |
8.174200E-01 |
| Stage1-vs-Stage4 |
7.725200E-01 |
| Stage2-vs-Stage3 |
4.138200E-01 |
| Stage2-vs-Stage4 |
4.777200E-01 |
| Stage3-vs-Stage4 |
8.865400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.04599999997779E-06 |
| Normal-vs-AfricanAmerican |
2.371600E-04 |
| Normal-vs-Asian |
5.947600E-01 |
| Caucasian-vs-AfricanAmerican |
7.864800E-01 |
| Caucasian-vs-Asian |
2.450600E-01 |
| AfricanAmerican-vs-Asian |
2.377200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.25469999998374E-06 |
| Normal-vs-Female |
4.20429999999916E-05 |
| Male-vs-Female |
5.810400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.276500E-02 |
| Normal-vs-Extreme_Weight |
8.25429999999905E-05 |
| Normal-vs-Obese |
2.763800E-04 |
| Normal-vs-Extreme_Obese |
3.775400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.883560E-01 |
| Normal_Weight-vs-Obese |
1.839000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.455200E-01 |
| Extreme_Weight-vs-Obese |
8.655000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.941050E-01 |
| Obese-vs-Extreme_Obese |
2.080000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.463300E-03 |
| Normal-vs-Age(41-60Yrs) |
2.72250000321606E-08 |
| Normal-vs-Age(61-80Yrs) |
5.195400E-04 |
| Normal-vs-Age(81-100Yrs) |
2.764800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.875600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.980800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.614400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.777800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.746000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.602000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.0176999959709E-08 |
| Normal-VS-Type2 PRCC |
3.322400E-02 |
| Normal-VS-KIRP CIMP |
1.118240E-02 |
| Normal-VS-Unclassified PRCC |
2.618000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.717200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.338400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.024600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.053350E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.843610E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.385400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.411690E-02 |
| Normal-vs-N1 |
2.935400E-03 |
| Normal-vs-N2 |
4.256200E-01 |
| N0-vs-N1 |
3.923800E-01 |
| N0-vs-N2 |
8.279400E-01 |
| N1-vs-N2 |
8.547800E-01 |
|
|
